GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced Parkinsonism
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 105 (2), 177-183
- https://doi.org/10.1016/0014-4886(89)90117-9
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Treatment with GM1 Ganglioside Restores Striatal Dopamine in the 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Treated MouseJournal of Neurochemistry, 1988
- Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouseJournal of the Neurological Sciences, 1987
- Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosidesActa Physiologica Scandinavica, 1985
- Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxinsJournal of Neuroscience Research, 1984
- Biology of gangliosides: Neuritogenic and neuronotrophic propertiesJournal of Neuroscience Research, 1984
- Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting*Acta Physiologica Scandinavica, 1983
- The toxicology of a ganglioside extract (Cronassial®)Toxicology Letters, 1983
- Selective modulation of3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the ratActa Physiologica Scandinavica, 1983
- Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growthBrain Research, 1980
- Über die Natur der Phosphatide und anderer Lipoide des Gehirns und der Leber bei der Niemann-Pickschen Krankheit. [12. Mitteilung über Phosphatide.]Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1935